PEG-MGF peptide, also known as PEG-MGF, is a biologically active molecule with similar activity to natural growth factors, but with a longer half-life and higher stability. Usually white or nearly white powder, insoluble in water, soluble in organic solvents such as methanol and acetonitrile. It is obtained by modifying polyethylene glycol (PEG) chains on the basis of natural growth factors. The length and modification method of PEG chains can affect the conformation and biological activity of molecules. The stability is significantly higher than that of unmodified growth factors. The introduction of polyethylene glycol can reduce the enzymatic degradation of growth factors and renal filtration, resulting in an extended half-life in the body. Due to the high molecular weight of PEG-MGF, it is not easy to pass through the cell membrane. Compared with natural growth factors, the permeability of PEG-MGF is reduced, but it can still effectively stimulate cell growth and differentiation. PEG-MGF retains the biological activity of natural growth factors, can bind to corresponding receptors and activate cell signal transduction pathways, promoting cell proliferation, differentiation, and apoptosis. PEG-MGF has good compatibility when used in combination with other drugs or bioactive substances. It will not have significant interactions with other drugs or bioactive substances. As a bioactive molecule, it has multiple uses and advantages. It has broad application prospects and market potential in fields such as drug carriers, gene therapy, biomaterials, cell culture, immune modulators, diagnostic reagents, and drug research and development.
|
Customized Bottle Caps And Corks:
|
|
PEG-MGF peptide, also known as polyethylene glycol based muscle growth promoting factor, is a biologically active molecule with broad application prospects. The following are some of the main uses of PEG-MGF:
1. Drug carrier: PEG-MGF can serve as a drug carrier and combine with drugs to form polymer drugs. This polymer drug can extend the half-life of the drug, improve its stability and bioavailability, and reduce its side effects. For example, PEG-MGF can combine with anti-tumor drugs to form polymer drugs, which can significantly improve the effectiveness of tumor treatment and reduce drug damage to normal tissues.
2. Gene therapy: PEG-MGF can also serve as a gene therapy vector to deliver therapeutic genes (such as tumor suppressor genes, recombinant proteins, etc.) to target cells. The efficacy and safety of this gene therapy method have been significantly improved, and it is expected to provide new ideas and methods for the treatment of many diseases.
3. Biomaterial: PEG-MGF has excellent biocompatibility and biological activity, and can be used as a biomaterial. For example, PEG-MGF can be used to manufacture medical devices and tissue engineering products such as artificial blood vessels and joints. These medical devices and tissue engineering products have good biocompatibility and durability, which can improve medical efficacy and patient quality of life.
4. Cell culture: PEG-MGF can serve as a component of the cell culture matrix, promoting cell adhesion, proliferation, and differentiation. PEG-MGF has good biocompatibility and chemical stability, providing the necessary nutrients for cell growth, improving the growth environment and biological performance of cells.
5. Immunomodulators: PEG-MGF can act as an immune modulator by regulating the immune response of the body. For example, PEG-MGF can stimulate the proliferation and differentiation of immune cells (such as T lymphocytes, macrophages, etc.) in the body, enhance the immune function of the body, and be used for treatment in areas such as anti infection and anti-tumor.
6. Diagnostic reagent: PEG-MGF can also be used as a component of diagnostic reagents for the preparation of in vitro or in vivo diagnostic reagents. For example, PEG-MGF can bind to specific antibodies or antigens to form specific complexes for detecting biological molecules such as pathogens and tumor markers, providing accurate and reliable information for clinical diagnosis.
7. Drug development: PEG-MGF also has a wide range of applications in drug development. For example, the biological activity of PEG-MGF can be utilized to conduct experiments on new drug screening, pharmacodynamics, and pharmacokinetics. Meanwhile, PEG-MGF can also serve as one of the research targets for drug action, providing new ideas and methods for drug design and discovery.
The synthesis method of PEG-MGF, a polyethylene glycol based muscle growth promoting factor, includes the following steps:
1. Preparation of required materials and reagents: Growth factors and PEG derivatives (such as mPEG-NHS or mPEG-COOH) need to be pre dissolved in suitable solvents (such as deionized water or methanol), while preparing other buffer solutions and reagents (such as NaOH, NMM, etc.).
2. Dissolve the growth factor in an appropriate buffer solution and adjust the pH value of the solution to an appropriate range (usually between 7-9) to ensure the stability of the growth factor.
3. Add PEG derivatives (mPEG-NHS or mPEG-COOH) to the above solution to react with growth factors.
React at a certain temperature and stirring conditions for a period of time (usually between 20-60 ℃, reaction time 2-24 hours) to fully combine PEG molecules with growth factors.
4. During the reaction process, attention should be paid to monitoring the reaction process, and product concentration and purity can be detected through methods such as HPLC and SDS-PAGE.
5. After the reaction is completed, the unreacted mPEG-NHS or mPEG-COOH and small molecule substances in the buffer solution are removed through dialysis, ultrafiltration, and other methods.
6. Finally, white or nearly white powder of PEG-MGF peptide can be obtained through methods such as freeze-drying.
The following is the reaction equation for the above synthesis method:
1. If PEG-MGF is synthesized through coupling reaction, the reaction equation can be expressed as:
Growth factor (protein)+mPEG-NHS → PEG-MGF (protein)
Among them, NHS in mPEG-NHS represents the N-hydroxysuccinimide group, which can react with amino groups on the surface of proteins to form polymer complexes.
2. If PEG-MGF is synthesized through amide bonds, the reaction equation can be expressed as:
Growth factor (protein)+mPEG-COOH → PEG-MGF (protein)
Among them, COOH in mPEG-COOH represents carboxyl groups, which can react with amino groups on the surface of proteins to form polymer complexes.
It should be noted that these reaction equations only represent the main reaction process for synthesizing PEG-MGF, and the actual reaction may include multiple side reactions and impurity generation. Therefore, strict control of reaction conditions and purification methods is required during synthesis to ensure the quality and stability of the final product. In addition, it is also necessary to pay attention to safety and environmental protection issues in practical operation.
Hot Tags: peg mgf peptide cas 108174-48-7, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale, dermorphin peptide, Cosmetic, Melanotan ii powder, dermorphin in humans, DERMORPHIN